NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes (2017)
Fonte: Journal of Autoimmune Disorders. Unidade: FMRP
Assuntos: DIABETES MELLITUS, INSULINA, IMUNOLOGIA
ABNT
CARLOS, Daniela et al. NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes. Journal of Autoimmune Disorders, v. 3, n. 2, 2017Tradução . . Disponível em: https://doi.org/10.21767/2471-8513.100033. Acesso em: 02 out. 2024.APA
Carlos, D., Costa, F. R. C., Leite, J. A., André, C. A., Tostes, R. de C. A., Carneiro, F. S., et al. (2017). NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes. Journal of Autoimmune Disorders, 3( 2). doi:10.21767/2471-8513.100033NLM
Carlos D, Costa FRC, Leite JA, André CA, Tostes R de CA, Carneiro FS, Câmara NOS, Silva JS da. NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes [Internet]. Journal of Autoimmune Disorders. 2017 ; 3( 2):[citado 2024 out. 02 ] Available from: https://doi.org/10.21767/2471-8513.100033Vancouver
Carlos D, Costa FRC, Leite JA, André CA, Tostes R de CA, Carneiro FS, Câmara NOS, Silva JS da. NLRP3 inflammasome: From pathogenesis to therapeutic strategies in Type 1 Diabetes [Internet]. Journal of Autoimmune Disorders. 2017 ; 3( 2):[citado 2024 out. 02 ] Available from: https://doi.org/10.21767/2471-8513.100033